In 2015 The Pharma And Biotech Industry Was Diagnosed With What Was Coined As Merger Fever Industry Analysts State That The First Half Of 2015 Soared Past 2014s Grand Total Of 162 Billion With The Total Value Of Pharma Mas In The First Two Quarte
In 2015, the pharma and biotech industry was diagnosed with what was coined as merger fever. Industry analysts state that the first half of 2015 soared past 2014’s grand total of $162 billion, with the total value of pharma M&As in the first two quarte
Pharma & Biotech’s Merger Fever: The Highlights
Please note: That all fields marked with an asterisk (*) are required.